| Company Name: |
Sichuan Wei Keqi Biological Technology Co., Ltd.
|
| Tel: |
028-81700200 18116577057 |
| Email: |
3003855609@qq.com |
| Products Intro: |
Product Name:Cysteineproteaseinhibitor-2 CAS:612048-23-4 Purity:98% Package:5mg;10mg;20mg;50mg;100mg;200mg;500mg;1g
|
| Company Name: |
Birdo (Shanghai) Medical Technology Co., Ltd.
|
| Tel: |
021-58099077 |
| Email: |
sales@birdochem.com |
| Products Intro: |
Product Name:(9E)?-?9-?hydroxyiminoindeno[1?,?2-?e]?pyrazine-?2,?3-?dicarbonitrile CAS:612048-23-4 Purity:98% Package:5mg, 25mg, 100mg, 250mg, 1g, 10g
|
(9E)-9-hydroxyiminoindeno[1,2-e]pyrazine-2,3-dicarbonitrile manufacturers
|
| | (9E)-9-hydroxyiminoindeno[1,2-e]pyrazine-2,3-dicarbonitrile Basic information |
| Product Name: | (9E)-9-hydroxyiminoindeno[1,2-e]pyrazine-2,3-dicarbonitrile | | Synonyms: | (9E)-9-hydroxyiminoindeno[1,2-e]pyrazine-2,3-dicarbonitrile;BZMDRVFGCPWHPO-LDADJPATSA-N;Cysteine protease inhibitor-2;Cysteine protease inhibitor-2,assay,USP8,inhibit,protease,Cysteine protease inhibitor2,Cathepsin B,UCH-L3,USP5,Cysteine,Caspase 3,Inhibitor,activity,Cathepsin,Cysteine protease inhibitor 2;9H-Indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 9-(hydroxyimino)- | | CAS: | 612048-23-4 | | MF: | C13H5N5O | | MW: | 247.21 | | EINECS: | | | Product Categories: | | | Mol File: | 612048-23-4.mol | ![(9E)-9-hydroxyiminoindeno[1,2-e]pyrazine-2,3-dicarbonitrile Structure](CAS/20180703/GIF/612048-23-4.gif) |
| | (9E)-9-hydroxyiminoindeno[1,2-e]pyrazine-2,3-dicarbonitrile Chemical Properties |
| Boiling point | 597.2±50.0 °C(Predicted) | | density | 1.53±0.1 g/cm3(Predicted) | | storage temp. | 4°C, stored under nitrogen, away from moisture | | pka | 7.23±0.20(Predicted) |
| | (9E)-9-hydroxyiminoindeno[1,2-e]pyrazine-2,3-dicarbonitrile Usage And Synthesis |
| Biological Activity | Cysteine protease inhibitor-2 is a cysteine protease inhibitor extracted from patent US20070032499A1, compound 12. Cysteine protease inhibitor-2 inhibits the cells growth of DCT116 and PC3 cells with GI50 values of 6.5 μM and 4.4 μM, respectively[1]. | | References | [1]. Philippe Guedat, et al. Novel cysteine protease inhibitors and their therapeutic applications. US20070032499A1. |
| | (9E)-9-hydroxyiminoindeno[1,2-e]pyrazine-2,3-dicarbonitrile Preparation Products And Raw materials |
|